BioElectronics Supports Arthritis Campaign

  • September 21st, 2015
  • News
  • 0 Comments
  • bfichter

Osteoarthritis is the Most Common Cause of Disability FREDERICK, MD. September 21, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced that they are sponsoring the Arthritis Care Time for Tea campaign October 12-18, 2015. Time for Tea is organized by Arthritis Care, a registered UK charity […]

BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference

  • August 27th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD, USA, August 27, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that three abstracts featuring the use of ActiPatch®, its novel musculoskeletal pain therapy, will be presented at the 9th Congress of the European Pain Federation EFIC®, Vienna, Austria, 2-5th September 2015. The Company will […]

BioElectronics Reports Stronger Second Quarter Results

  • August 18th, 2015
  • News
  • 0 Comments
  • bfichter

Publishes Market Analysis of its Try & Tell Survey That Predicts Strong Ongoing Sales

FREDERICK, MD, USA, August 18, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today published on its second quarter financial results along with a market analysis of its long term follow up surveys of customers who are managing pain with ActiPatch Therapy.

BioElectronics Files FDA Premarket Notification for ActiPatch® Therapy

  • August 10th, 2015
  • News
  • 0 Comments
  • bfichter

The Most Innovative Treatment for Chronic Pain FREDERICK, MD. August 10, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced the filing of a 510(k) Premarket Notification for ActiPatch® Therapy with the U.S. Food and Drug Administration. The market clearance request is for the adjunctive treatment of […]

BioElectronics’ Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal

  • August 4th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD, USA, August 4, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of drug-free over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, announced today that its registry study of 44,000 users of its ActiPatch 7-day trial device has been published in the prominent peer reviewed medical journal Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35. More than 5,000 chronic […]

UpTick News Wire Radio Show Will Interview BioElectronics’ CEO Andrew Whelan

  • July 31st, 2015
  • News
  • 0 Comments
  • bfichter

Topics will Include UK Progress and New Clinical Publications FREDERICK, MD.  August 3, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President will be interviewed by Stu Taylor on his program “On Business“ at 9am EST on Wednesday, August 5th. Listen to […]

BioElectronics Expands Medical and OTC Distribution

  • March 24th, 2015
  • News
  • 0 Comments
  • bfichter

Appoints Market Leader, Medikon, LTD as distributor in Turkey FREDERICK, MD, USA, March 23, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced today that it has signed Medikon, one of the country’s leading medical suppliers as the distributor for RecoveryRx® Therapy for post-operative and chronic wound care, ActiPatch® Musculoskeletal […]

BioElectronics Executive Vice President Dr. Deepak Kotak Interviewed on CEOLive.TV – Explains the Changing Paradigm of Chronic Pain

  • February 9th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD, USA, February 9, 2015 — BioElectronics Corporation (OTC: BIEL), the maker of an industry leading family of bioelectric pain therapy devices, said today that its Executive Vice President, Dr. Deepak Kotak, was interviewed by CEOLIVE.TV as part of its Executive Interview Series. The entire interview is available at http://ceolive.tv/bioelectronics/biel-videos/2515-ceolive-tv-interview-dr-deepak-kotak-vp-of-bioelectronics-corp-biel In the interview, Dr. […]

BioElectronics’ ActiPatch® Actual-Use Survey Finds 90% Have Excellent Chronic Pain Management and 88% had a Decrease in Opioid Use

  • February 4th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD, USA, February 4, 2015– BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released analysis of its ongoing and second long term follow up survey of customers in the United Kingdom and Ireland who are managing chronic pain with ActiPatch® Therapy, and reducing their dependence on systemic pain […]

BioElectronics Announces B. Braun as the UK Distributor for Pain Device in Orthopaedics

  • January 14th, 2015
  • News
  • 0 Comments
  • bfichter

BioElectronics Corporation, USA, today announced that B. Braun Medical Ltd is the exclusive UK distributor of the BioElectronic’s RecoveryRx® pain device in orthopaedics and trauma. RecoveryRx® is a micro medical device that treats acute and chronic musculoskeletal pain and decreases oedema. RecoveryRx® will be introduced in the B. Braun enhanced recovery surgical programs, particularly hip […]